Quality Systems Stock Price Target and Analyst Ratings (NASDAQ:QSII)

Analyst Price Target for QSII

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$0.00

▼ -100.00% Downside Potential

This price target is based on 0 analysts offering 12 month price targets for Quality Systems in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $22.35.

N/A

The current consensus among 0 polled investment analysts is to n/a stock in Quality Systems. This rating has held steady since August 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

10/29/2019

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/27/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/26/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/25/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

10/23/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/21/2021

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/22/2021

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
9/10/2018	Cantor Fitzgerald	Boost Price Target	Overweight ➝ Overweight	$23.00 ➝ $26.00	Low	i
9/7/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$26.00	Low	i
8/2/2018	Royal Bank of Canada	Reiterated Rating	Sell	$17.00	Medium	i
8/1/2018	SunTrust Banks	Reiterated Rating	Hold	$20.00	Medium	i
8/1/2018	SVB Leerink	Set Price Target	Hold	$16.00 ➝ $22.00	High	i Rating by David Larsen at SVB Leerink LLC
8/1/2018	KeyCorp	Boost Price Target	Underweight ➝ Underweight	$12.00 ➝ $17.00	High	i
7/31/2018	Jefferies Financial Group	Set Price Target	Hold	$19.00	High	i Rating by Sean Dodge at Jefferies Financial Group Inc.
6/21/2018	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Buy	$21.00 ➝ $23.00	Low	i
5/31/2018	Cantor Fitzgerald	Downgrade	Overweight ➝ Neutral		Low	i
5/30/2018	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$21.00	High	i
5/25/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$22.00	High	i
4/24/2018	JPMorgan Chase & Co.	Initiated Coverage	Underweight ➝ Underweight	$14.00 ➝ $15.00	High	i Rating by Anne McCormick at JPMorgan Chase & Co.
1/26/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$17.00	Low	i
1/4/2018	Citigroup	Initiated Coverage	Sell ➝ Sell	$13.00	High	i
11/17/2017	SunTrust Banks	Reiterated Rating	Hold	$15.00	N/A	i
10/29/2017	Jefferies Financial Group	Reiterated Rating	Hold	$14.50	N/A	i
10/27/2017	Royal Bank of Canada	Set Price Target	Sell	$12.00	N/A	i
10/26/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$13.00	N/A	i
10/17/2017	Robert W. Baird	Reiterated Rating	Hold	$15.00	N/A	i
10/8/2017	Jefferies Financial Group	Reiterated Rating	Hold	$15.50	N/A	i
9/19/2017	Royal Bank of Canada	Initiated Coverage	Underperform ➝ Underperform	$12.00	High	i
9/17/2017	KeyCorp	Reiterated Rating	Sell		Low	i
9/17/2017	Robert W. Baird	Reiterated Rating	Hold	$15.00	Low	i
9/15/2017	Oppenheimer	Reiterated Rating	Hold		High	i
9/14/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$15.00	High	i
8/2/2017	Jefferies Financial Group	Reiterated Rating	Hold	$13.00 ➝ $15.50	Medium	i
8/1/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$16.00 ➝ $20.00	High	i
5/31/2017	SVB Leerink	Reiterated Rating	Market Perform	$14.00 ➝ $16.00	Medium	i
3/29/2017	Jefferies Financial Group	Reiterated Rating	Hold	$13.00	Low	i Rating by Sean Dodge at Jefferies Financial Group Inc.
1/16/2017	Jefferies Financial Group	Set Price Target	Hold	$13.00	N/A	i
1/5/2017	Cantor Fitzgerald	Initiated Coverage	Neutral	$14.00	N/A	i
12/2/2016	Dougherty & Co	Initiated Coverage	Neutral		N/A	i
11/29/2016	Raymond James	Downgrade	Outperform ➝ Market Perform		N/A	i
11/29/2016	Citigroup	Downgrade	Market Perform		N/A	i
10/28/2016	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$13.00 ➝ $11.00	N/A	i
10/27/2016	Oppenheimer	Reiterated Rating	Hold		N/A	i Rating by Mohan Naidu at Oppenheimer Holdings Inc.
10/5/2016	UBS Group	Initiated Coverage	Sell	$10.50	N/A	i
8/2/2016	Jefferies Financial Group	Reiterated Rating	Hold	$15.00 ➝ $13.00	N/A	i Rating by Sean Dodge at Jefferies Financial Group Inc.
8/1/2016	(FBRC)	Reiterated Rating	Hold		N/A	i Rating by Steven Halper at (FBRC)
7/29/2016	JPMorgan Chase & Co.	Lower Price Target	Neutral	$15.00 ➝ $13.00	N/A	i
7/29/2016	KeyCorp	Reiterated Rating	Sell	$11.00	N/A	i Rating by Donald Hooker at KeyCorp
7/29/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Sell	$12.00 ➝ $11.00	N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
6/8/2016	Jefferies Financial Group	Reiterated Rating	Hold		N/A	i Rating by Sean Dodge at Jefferies Financial Group Inc.
6/8/2016	SVB Leerink	Reiterated Rating	Hold		N/A	i Rating by David Larsen at SVB Leerink LLC
6/8/2016	Morgan Stanley	Reiterated Rating	Sell		N/A	i Rating by Zachary Sopcak at Morgan Stanley
6/8/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Sell	$13.00 ➝ $12.00	N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
6/8/2016	Oppenheimer	Reiterated Rating	Hold		N/A	i
6/2/2016	SunTrust Banks	Boost Price Target	Neutral	$12.00 ➝ $13.00	N/A	i
5/23/2016	Avondale Partners	Reiterated Rating	Market Perform	$14.00	N/A	i
5/22/2016	(FBRC)	Reiterated Rating	Hold		N/A	i Rating by Steven Halper at (FBRC)
5/22/2016	KeyCorp	Reiterated Rating	Sell		N/A	i Rating by Donald Hooker at KeyCorp
5/22/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Sell		N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
5/20/2016	Topeka Capital Markets	Lower Price Target	Buy	$18.00 ➝ $17.00	N/A	i
4/28/2016	Oppenheimer	Reiterated Rating	Hold		N/A	i

(Data available from 4/21/2016 forward)

NextGen Healthcare, Inc. engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support. The company was founded by Sheldon Razin in 1974 and is headquartered in Atlanta, GA.

Today's Range

Now: $22.35

$21.83

$22.37

50 Day Range

MA: N/A

52 Week Range

Now: $22.35

$12.24

$23.73

Volume

297,838 shs

Average Volume

176,064 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Quality Systems?

The following sell-side analysts have issued reports on Quality Systems in the last year:
View the latest analyst ratings for QSII.

What is the current price target for Quality Systems?

0 Wall Street analysts have set twelve-month price targets for Quality Systems in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Quality Systems in the next year.
View the latest price targets for QSII.

What is the current consensus analyst rating for Quality Systems?

Quality Systems currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for QSII.

What other companies compete with Quality Systems?

Other companies that are similar to Quality Systems include Cerner, Omnicell, HMS, Allscripts Healthcare Solutions, Vocera Communications, Cortexyme, HealthStream and Computer Programs and Systems.

How do I contact Quality Systems' investor relations team?

Quality Systems' physical mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company's listed phone number is (949) 255-2600 and its investor relations email address is [email protected] The official website for Quality Systems is www.nextgen.com.

NASDAQ:QSII - Quality Systems Stock Price Target and Predictions

Analyst Price Target for QSII

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Quality Systems?

What is the current price target for Quality Systems?

What is the current consensus analyst rating for Quality Systems?

What other companies compete with Quality Systems?

How do I contact Quality Systems' investor relations team?